Viewing Study NCT00627003


Ignite Creation Date: 2025-12-24 @ 7:43 PM
Ignite Modification Date: 2026-04-19 @ 3:03 AM
Study NCT ID: NCT00627003
Status: COMPLETED
Last Update Posted: 2011-04-25
First Post: 2008-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Restless Legs Syndrome View
Keywords: